Clinical Trial Update: Safety Study of ChimeriVax™-JE Vaccine to Prevent Japanese Encephalitis. [Phase 3]

View source ↗

Summary

A Phase 3 safety trial evaluated the ChimeriVax-JE vaccine for preventing Japanese encephalitis. The study has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Encephalitis
• Japanese Encephalitis

Drugs mentioned

• ChimeriVax-JE vaccine

Snippet

Sponsor: Sanofi | Conditions: Encephalitis, Japanese Encephalitis | Phase 3 | Status: COMPLETED | Results posted: 2012-12-05